Found: 7
Select item for more details and to access through your institution.
Cabozantinib plus docetaxel and prednisone in metastatic castration‐resistant prostate cancer.
- Published in:
- BJU International, 2021, v. 127, n. 4, p. 435, doi. 10.1111/bju.15227
- By:
- Publication type:
- Article
Phase II trial of docetaxel, bevacizumab, lenalidomide and prednisone in patients with metastatic castration-resistant prostate cancer.
- Published in:
- BJU International, 2016, v. 118, n. 4, p. 590, doi. 10.1111/bju.13412
- By:
- Publication type:
- Article
A phase I study of TRC105 anti-endoglin ( CD105) antibody in metastatic castration-resistant prostate cancer.
- Published in:
- BJU International, 2015, v. 116, n. 4, p. 546, doi. 10.1111/bju.12986
- By:
- Publication type:
- Article
Phase I Single-Arm Study of Biweekly NHS-IL12 in Patients With Metastatic Solid Tumors.
- Published in:
- Oncologist, 2023, v. 28, n. 4, p. 364, doi. 10.1093/oncolo/oyac244
- By:
- Publication type:
- Article
A Phase II Single Arm Pilot Study of the CHK1 Inhibitor Prexasertib (LY2606368) in BRCA Wild‐Type, Advanced Triple‐Negative Breast Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. 1013, doi. 10.1634/theoncologist.2020-0491
- By:
- Publication type:
- Article
Racial Disparities in the Association Between Variants on 8q24 and Prostate Cancer: A Systematic Review and Meta-Analysis.
- Published in:
- Oncologist, 2012, v. 17, n. 3, p. 312, doi. 10.1634/theoncologist.2011-0315
- By:
- Publication type:
- Article
Stem cell dynamics and cellular heterogeneity across lineage subtypes of castrate-resistant prostate cancer.
- Published in:
- Stem Cells, 2024, v. 42, n. 6, p. 526, doi. 10.1093/stmcls/sxae025
- By:
- Publication type:
- Article